Multiple squamous cell carcinomas of the skin during long-term treatment with hydroxyurea

European Journal of Dermatology

Volumn 8, Issue 2, 1998, Pages 114-115

  De Simone, Clara ^a   Guerriero, Cristina ^a   Guidi, Beatrice ^a   Rotoli, Maurizio ^a   Venier, Antonio ^a   Tartaglione, Raffaele ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Actinic keratoses; Antimitotic drugs; Carcinogenesis; Hydroxyurea; Myeloproliferative disorders; Skin carcinoma

Indexed keywords

BUSULFAN; HYDROXYUREA;

ACTINIC KERATOSIS; ADULT; ALOPECIA; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DERMATOMYOSITIS; HUMAN; HYPERPIGMENTATION; KERATODERMA; LEG ULCER; MALE; METASTASIS; MYELOPROLIFERATIVE DISORDER; SKIN ATROPHY; SQUAMOUS CELL CARCINOMA;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; FACE; HUMANS; HYDROXYUREA; LEUKEMIA, MYELOID, CHRONIC; MALE; NEOPLASMS, SECOND PRIMARY; SKIN NEOPLASMS;

EID: 0031919422     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bolin RW, Robinson WA, Sutherland J, et al. Busulfan versus hydroxyurea in the long-term therapy of chronic myelogenous leukemia. Cancer 1982; 50: 1683-6.
2. Kennedy BS, Smith LR, Goltz RW. Skin changes secondary to hydroxyurea therapy. Arch Dermatol 1975; 11: 183-7.
3. Gropper CA, Don PC, Sadjadi MM. Nail and skin hyperpigmentation associated with hydroxyurea therapy for polycythemia vera. Int J Dermatol 1993; 32: 731-3.
4. Nquyen TV, Margolis DJ. Hydroxyurea and lower leg ulcers. Cutis 1993; 52: 217-9.
5. Sigal M, Crickx B, Blanchet P, et al. Lésions cutanées induites par l'utilisation au long cours de l'hydroxyurea en chronic myelogenous leukemia. Ann Dermatol Venereol 1984; 111: 895-900.
6. Richard M, Truchetet F, Friedel J, et al. Skin lesions simulating dermatomyositis during long-term hydroxyurea therapy. J Am Acad Dermatol 1989; 21: 797-9.
7. Weber LL, Schick E, Merkel M, et al. Dermatomyositis-like skin changes with long-term hydroxyurea (Litalir) therapy. Hautartz 1995; 46: 717-21.
8. Daoud MS, Gibson LE, Pittelkow MR. Hydroxyurea dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea. J Am Acad Dermatol 1997; 36: 178-82.
9. Papi M, Didona B, De Pità O, et al. Multiple skin tumors on light exposed areas during long-term treatment with hydroxyurea. J Am Acad Dermatol 1993; 28: 485-6.
10. Grange F, Couillet D, Audhuy B, et al. Kératoses multiples induites par l'hydroxyurée. Ann Dermatol Venereol 1995; 122: 16-8.
11. Klem EB. Effects of antipsoriasis drugs and methabolic inhibitors on the growth of epidermal cells in culture. J Invest Dermatol 1978; 70: 27-32.
12. Francis AA, Blevins RD, Carrier WL, et al. Inhibition of DNA repair in ultraviolet-irradiated human cells by hydroxyurea. Biochem Bhiophys Acta 1979; 563: 385-92.
13. Timson J. Hydroxyurea. Mutat Res 1975; 32: 115-32.